This is a single center, double-blind (patient and investigator), randomized,
placebo-controlled study with a split-lesion design, in which selected keloids will receive
three consecutive treatments of a) bleomycin and b) placebo (saline (NaCl 0,9%)),
administered with an electronic pneumatic jet injector.